Current Trends and Challenges in Pharmacoeconomic Aspects of Nanocarriers as Drug Delivery Systems for Cancer Treatment
Sylwia Milewska,1 Katarzyna Niemirowicz-Laskowska,1 Gabriela Siemiaszko,2 Piotr Nowicki,1 Agnieszka Z Wilczewska,2 Halina Car1 1Department of Experimental Pharmacology, Medical University of Bialystok, Bialystok, 15-361, Poland; 2Faculty of Chemistry, University of Bialystok, Bialystok, 15-245, Pola...
Guardado en:
Autores principales: | Milewska S, Niemirowicz-Laskowska K, Siemiaszko G, Nowicki P, Wilczewska AZ, Car H |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/61a27f282df04deeb7f555f93121a95c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pharmacoeconomic effectiveness of phytotherapy in complex treatment of pyelonephritis
por: V. V. Ivanov, et al.
Publicado: (2015) -
PHARMACOECONOMICS OF APPLICATION OF HEPATOPROTECTORS IN THERAPY OF DRUG-INDUCED LIVER INJURY AFTER CHEMOTHERAPY
por: D. D. Morikov, et al.
Publicado: (2017) -
Pharmacoeconomic analysis of clinical efficiency of combined metformin (Siofor) - insulin therapy in patients with type 2 diabetes mellitus
por: I Yu Demidova, et al.
Publicado: (2009) -
Pharmacoeconomic simulation of delayed results of the treatment of type 2 diabetes mellitus with modern insulin analogsin comparison with oral hypoglycemic agents
por: Ivan Ivanovich Dedov, et al.
Publicado: (2010) -
Pharmacoeconomic analysis of conservative strategy for the treatment of patients with diabetic foot syndrome in Moscow
por: Marina Fedorovna Kalashnikova, et al.
Publicado: (2011)